KetoSwiss AG logo — Fuel for brains.

KetoSwiss AG

Fuel for brains.

Founded 2017 Switzerland Basel, Switzerland 9 employees Seed Total: $6.30M Biotechnology, Health Care

General Information

Company Name KetoSwiss AG
Founded Year 2017
Location Switzerland Basel, Switzerland
Founders / Decision Makers
Team member
Employees 9
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with KetoSwiss AG. To contact KetoSwiss AG, visit keto.swiss.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About KetoSwiss AG

KetoSwiss AG is a Swiss biotechnology company based in Basel, focusing on the development and clinical testing of a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and other related neurological diseases such as Alzheimer's disease. Founded in 2017, their lead product's active substance is an endogenous metabolite – a Ketone body, which serves as an alternative fuel source for the human brain when glucose utilization or transport is compromised. The company recently secured an $800.00K Seed Round investment on 03 August 2023 from notable investors including R42, Healthspan Capital, ORTHO INNOVATIONS, Baszucki Group, and The William K. Warren Foundation. This innovative concept aligns with the growing interest in biotechnology and health care industries. KetoSwiss AG's focus on addressing metabolic dysfunctions that are common in various neurological diseases provides an intriguing investment opportunity. The company's dedication to developing preventive solutions for these prevalent health conditions demonstrates its potential for long-term success, making it a compelling prospect for venture capital firms seeking impactful investments in the biotech and healthcare sectors.

Taxonomy: nutraceutical, medical food, migraines, neurological diseases, metabolic dysfunction, Alzheimer's disease, Ketone body, brain fuel, clinical testing, Swiss company, Basel, endogenous metabolite, glucose utilization, neurological therapy

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $800.00K 5
R42, Healthspan Capital +3
03 Aug 2023
Seed Round $4.00M 5
R42, Healthspan Capital +3
13 Oct 2022
Convertible Note Fr.1.50M -
16 Jul 2021

KetoSwiss AG Alternatives & Competitors

KetoSwiss AG vs
Therini Bio, Inc.
Therini Bio, Inc. United States

A new approach to block vascular-mediated inflammation

Series A
15 employees
Biotechnology, Health Care

FAQ About KetoSwiss AG

Fuel for brains.
KetoSwiss AG was founded in 2017.
KetoSwiss AG is headquartered in Basel, Switzerland.
KetoSwiss AG operates in Biotechnology and Health Care. Its work centres on nutraceutical, medical food, migraines and neurological diseases.
KetoSwiss AG has approximately 9 employees.
KetoSwiss AG has completed 3 funding rounds, raising a total of $6.30M. The latest funding stage is Seed.
Top alternatives and competitors to KetoSwiss AG include Therini Bio, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
KetoSwiss AG and Therini Bio, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for KetoSwiss AG, https://bouncewatch.com/company/ketoswiss-ag, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes